O
Ortho Rebirth
Innovative synthetic bone void fillers and cell culture technologies for regenerative medicine
About Ortho Rebirth
ORTHOREBIRTH specializes in developing innovative solutions for regenerative medicine, focusing on synthetic bone void fillers and cell culture technologies. Their flagship product, ReBOSSIS, is a cottony type synthetic bone void filling material that leverages proprietary Microfiber Producing Technology. This product is designed to be bioabsorbable and serves as an effective scaffolding material, making it highly suitable for various medical applications. The company collaborates with universities, institutions, and businesses to advance regenerative medicine, and has received R&D subsidies from Okinawa Prefecture to further their research. ORTHOREBIRTH generates revenue through the commercialization of its products, targeting research institutions and medical facilities that require advanced materials for regenerative treatments.
Source: Dealroom company dataNews
Open roles
Ortho Rebirth in the Yokohama ecosystem
The Ortho Rebirth office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
Kaigen Pharma
Dexerials
Sansei Capital Investment- LCLeading Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ortho Rebirth on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ortho Rebirth on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

